Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib Plus Interferon Alpha in Metastatic Renal Cell Carcinoma
NCT01158534Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Mar 2006
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib oral solution in renal cell carcinoma (RCC), sponsored by Case Comprehensive Cancer Center. Started Mar 2006; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01158534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01158534.